SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-010219
Filing Date
2019-05-16
Accepted
2019-05-16 14:32:12
Documents
3
Period of Report
2019-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cenb20190516_8k.htm 8-K 37648
2 EXHIBIT 10.1 ex_145243.htm EX-10.1 72759
3 EXHIBIT 10.2 ex_145244.htm EX-10.2 36301
  Complete submission text file 0001437749-19-010219.txt   148065
Mailing Address 7405 TECUMSEH ROAD EAST SUITE 300 WINDSOR A6 N8T 1G2
Business Address 7405 TECUMSEH ROAD EAST SUITE 300 WINDSOR A6 N8T 1G2 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55557 | Film No.: 19831840
SIC: 2834 Pharmaceutical Preparations